Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Therapeutic Drug Monitoring Market Grown from 2024 to 2025?

The market size of therapeutic drug monitoring has seen substantial growth in the past few years. We anticipate it will expand from $2.23 billion in 2024 to $2.43 billion in 2025, recording a compound annual growth rate (CAGR) of 8.9%. Factors such as the increase in chronic disease cases, concerns about drug safety, the incorporation of pharmacogenomics, the uptick in drug development, and regulatory focus on precision medicine have contributed to the growth in the historic period.

What Growth Rate Is Anticipated for the Therapeutic Drug Monitoring Market in the Coming Years?

In the upcoming years, we can anticipate a swift expansion in the market size of therapeutic drug monitoring, with a projection to reach “$3.72 billion by 2029, experiencing a compound annual growth rate (CAGR) of 11.3%. This phenomenal growth in the forecast period can be credited to numerous factors including the increased use in oncology, the surge in personalized medicine practices, the global rise in the aging population, more accessible point-of-care testing, and an uptick in pharmaceutical r&d spending. Key trends expected to shape this perspective include personalized medicine, technological progression, accelerated drug development and utilization, the prevalence of point-of-care testing (poct), and the emergence of novel biomarkers and assay technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10069&type=smp

Who Are the Leading Companies in the Therapeutic Drug Monitoring Market?

Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

What Are the Key Drivers of the Therapeutic Drug Monitoring Market?

An increase in organ transplant operations is anticipated to bolster the expansion of the therapeutic drug monitoring (TDM) market. Organ transplantation involves surgically moving an organ from one person (the donor) to another. It’s been noted that the TDM of immuno-suppressive drugs effectively controls patients encountering solid organ transplantation. Optimizing TDM could prevent the possibilities of toxic or inadequately low-dosage treatment leading to organ rejection. For example, an article published by the United Network for Organ Sharing in January 2023 stated that 42,887 organ transplants were conducted in the US in 2022, marking a 3.7% growth from 2021. Hence, it is surmised that the escalation in organ transplant operations is fueling the growth of the therapeutic drug monitoring market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10069&type=smp

What Are the Key Market Segments in the Therapeutic Drug Monitoring Industry?

The therapeutic drug monitoring market covered in this report is segmented –

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors

2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms

3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs

4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:

1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards

2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment

3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers

4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques

What Are the Latest Trends in the Therapeutic Drug Monitoring Market?

Leading businesses in the therapeutic drug monitoring sector are focusing on advancing anti-idiotypic antibody technology to boost the accuracy and sensitivity of assays that measure biologic drug levels and evaluate patient immune responses. Anti-idiotypic antibody technology has proven beneficial in therapeutic drug monitoring, facilitating exact detection and measurement of biologic drug levels, confirming accurate dosage, and monitoring patient immune responses. In June 2024, Bio-Rad Laboratories, an American biotech firm, introduced new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies to enhance the efficacy of bioanalytical assays, thereby increasing the precision of pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These progressive antibodies elevate the dependability of antibody-drug conjugates (ADCs) assays and are vital for the therapeutic drug monitoring market, providing accurate evaluations of drug levels and immune responses for ideal patient dosing.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/therapeutic-drug-monitoring-global-market-report

What Are the Key Regional Markets in the Therapeutic Drug Monitoring Industry?

North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10069

This Report Delivers Insight On:

1. How big is the therapeutic drug monitoring market, and how is it changing globally?

2. Who are the major companies in the therapeutic drug monitoring market, and how are they performing?

3. What are the key opportunities and risks in the therapeutic drug monitoring market right now?

4. Which products or customer segments are growing the most in the therapeutic drug monitoring market?

5. What factors are helping or slowing down the growth of the therapeutic drug monitoring market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model